Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59) becomes the first authorized COVID-19 treatment approved from the Korean Ministry of Food and Drug Safety (MFDS)
• The approval marks the primary time a monoclonal antibody remedy for COVID-19 obtained full approval ...
Read more